altretamine has been researched along with Thrombocytopenia in 10 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
Thrombocytopenia: A subnormal level of BLOOD PLATELETS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lithium carbonate ameliorates neutropenia associated with cancer chemotherapy." | 7.67 | The effect of lithium carbonate on chemotherapy-induced neutropenia and thrombocytopenia. ( Herbst, AL; Makii, MM; Richman, CM; Weiser, PA, 1984) |
| "Lithium carbonate ameliorates neutropenia associated with cancer chemotherapy." | 3.67 | The effect of lithium carbonate on chemotherapy-induced neutropenia and thrombocytopenia. ( Herbst, AL; Makii, MM; Richman, CM; Weiser, PA, 1984) |
| "Thirty-eight women with advanced ovarian cancer were given monthly cycles of intravenous cyclophosphamide, Adriamycin (doxorubicin) and cis-platin, and oral hexamethylmelamine." | 1.27 | Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdens. ( Arseneau, J; Bennett, B; Greenwald, E; Kaplan, BH; Pagano, M; Vogl, SE, 1983) |
| "Twenty-three patients with metastatic breast carcinoma were induced with a complex systemic therapy regimen in an attempt to ascertain if a complete remission rate greater than 50% could be obtained with intensive drug exposure." | 1.27 | Short term high density systemic therapy for metastatic breast cancer. ( Carbone, PP; Davis, TE; Kline, JC; Love, RR; Palta, M; Tormey, DC, 1985) |
| "Thirty-eight women with advanced ovarian cancer resistant to alkylating-agent chemotherapy were treated with a combination of hexamethylmelamine and cisplatin." | 1.26 | Hexamethylmelamine and cisplatin in advanced ovarian cancer after failure of alkylating-agent therapy. ( Arseneau, JC; Davis, TE; Einhorn, N; Kaplan, BH; Pagano, M; Tunca, JC; Vogl, SE, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vogl, SE | 2 |
| Pagano, M | 2 |
| Davis, TE | 2 |
| Einhorn, N | 1 |
| Tunca, JC | 1 |
| Kaplan, BH | 2 |
| Arseneau, JC | 1 |
| Edwards, CL | 1 |
| Herson, J | 1 |
| Gershenson, DM | 1 |
| Copeland, LJ | 1 |
| Wharton, JT | 1 |
| Greenwald, E | 1 |
| Arseneau, J | 1 |
| Bennett, B | 1 |
| Neijt, JP | 1 |
| ten Bokkel Huinink, WW | 1 |
| van der Burg, ME | 1 |
| van Oosterom, AT | 1 |
| Kooyman, CD | 1 |
| van Houwelingen, JC | 1 |
| Pinedo, HM | 1 |
| Richman, CM | 1 |
| Makii, MM | 1 |
| Weiser, PA | 1 |
| Herbst, AL | 1 |
| Chahinian, AP | 1 |
| Green, G | 1 |
| Holland, JF | 1 |
| Wilson, WL | 1 |
| Ryzin, JV | 1 |
| Weiss, AJ | 1 |
| Frelick, RW | 1 |
| Moss, SE | 1 |
| Tormey, DC | 1 |
| Kline, JC | 1 |
| Palta, M | 1 |
| Love, RR | 1 |
| Carbone, PP | 1 |
| Markman, M | 1 |
| Abeloff, MD | 1 |
| Berkman, AW | 1 |
| Waterfield, WC | 1 |
3 trials available for altretamine and Thrombocytopenia
| Article | Year |
|---|---|
A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancer.
Topics: Adult; Altretamine; Anemia; Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Cyclophospha | 1983 |
Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cy | 1984 |
A phase III study in lung carcinoma comparing hexamethyl-melamine (NSC 13875) to dibromodulcitol (NSC 104800) 1,2.
Topics: Adenocarcinoma; Altretamine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Top | 1975 |
7 other studies available for altretamine and Thrombocytopenia
| Article | Year |
|---|---|
Hexamethylmelamine and cisplatin in advanced ovarian cancer after failure of alkylating-agent therapy.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Altretamine; Cisplatin; Cystadenocarcinoma; D | 1982 |
Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdens.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cis | 1983 |
Combination chemotherapy with or without hexamethylmelamine in alkylating-agent resistant ovarian carcinoma.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Humans; | 1984 |
The effect of lithium carbonate on chemotherapy-induced neutropenia and thrombocytopenia.
Topics: Agranulocytosis; Altretamine; Cisplatin; Colony-Stimulating Factors; Cyclophosphamide; Doxorubicin; | 1984 |
Short term high density systemic therapy for metastatic breast cancer.
Topics: Altretamine; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Combined Modality Therapy; Doxorubi | 1985 |
Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.
Topics: Actuarial Analysis; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow D | 1985 |
Phase II trials of hexamethylmelamine, dianhydrogalactitol, razoxane, and beta-2'-deoxythioguanosine as single agents against advanced measurable tumors of the pancreas. Gastrointestinal Tumor Study Group.
Topics: Adenocarcinoma; Altretamine; Antineoplastic Agents; Deoxyguanosine; Dianhydrogalactitol; Drug Evalua | 1985 |